Skip to main content
. 2022 Aug 4;10:923170. doi: 10.3389/fpubh.2022.923170

Figure 1.

Figure 1

Schematic workflow for the experimental approach using untargeted metabolomics. The plasma were collected from NC, MT and MTS groups for metabolomics profiling using untargeted metabolomics. Quantitative information is extracted from MS data and identification based on database, and the metabolic pathways of differential metabolites were enriched and the potential biomarkers were further obtained, subsequently, the availability was predicted and the correlations between potential biomarkers and clinical characteristics were analyzed.